Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors.

The main programme for the 26th Annual BEF is spread throughout 2 days (7th – 8th of October) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the plenary Rising Stars – Biotech Seed Companies Session, covering biotech, drug discovery, and diagnostic start-ups from across Europe. In addition, there will be virtual company showcases available on demand during the virtual week.